At AGBT, researchers reveal new findings from studies leveraging Illumina’s multiomics solutions SAN DIEGO, Feb. 25, 2026 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) today announced new customer breakthroughs in oncology powered by Illumina’s spatial transcriptomics, 5-base sequencing,…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
